Lymphoma Clinical Trials in Arizona

Showing 301-320 of 541 trials

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT01261247

Panobinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying how well panobinostat works in treating patients with relapsed or refractory non-Hodgkin lymphoma

Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+18 more

Mayo Clinic41 participantsStarted Jan 2011

Scottsdale, Arizona, United States • Rochester, Minnesota, United States

COMPLETEDPhase 333 miles

ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas

NCT01777152

This is a double-blind, randomized, multicenter, phase 3 clinical trial to compare the efficacy and safety of brentuximab vedotin in combination with CHP with the standard-of-care CHOP in patients with CD30-positive mature T-cell lymphomas.

Anaplastic Large-Cell LymphomaNon-Hodgkin LymphomaT-Cell Lymphoma

Seagen Inc.452 participantsStarted Jan 2013

Gilbert, Arizona, United States • Duarte, California, United States • Stanford, California, United States +141 more locations

PreviousPage 16 of 28Next

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas

Lymphoma Trials in Other Cities

A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Double Cord Versus Haploidentical (BMT CTN 1101)

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies

Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas

A Study of LY3023414 in Participants With Advanced Cancer

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Phase 1, Dose-Escalation Study of IGN002 in NHL Subjects

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

Other Conditions in Arizona